Clinical Trials Directory

Trials / Completed

CompletedNCT06525454

Individualized Automatic Target Coaching Message for Glycemic Management and Depressive Symptom

Feasibility and Acceptability of Individualized Automatic Target Coaching Message Based on the Metrics of Continuous Glucose Monitoring and Depressive Symptom

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years – 69 Years
Healthy volunteers
Not accepted

Summary

This is a single-center, randomized, prospective, feasibility and acceptability trial in patients with type 1 diabetes. For six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires. The control group will remain on their current treatment and will not receive any intervention. The purpose of this trial is to evaluate the feasibility and acceptability of the clinical application of automated, personalized coaching messages for glycemic management and depressive symptom in people with type 1 diabetes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPersonalized coaching messages for blood glucose and emotionsFor six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires.

Timeline

Start date
2024-08-07
Primary completion
2024-09-18
Completion
2024-09-30
First posted
2024-07-29
Last updated
2024-11-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06525454. Inclusion in this directory is not an endorsement.